ArticleJournal of translational medicine2021

CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.